1997
Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)
Quirós P, Jones G, Kacinski B, Braverman I, Heald P, Edelson R, Wilson L. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). International Journal Of Radiation Oncology • Biology • Physics 1997, 38: 1027-1035. PMID: 9276369, DOI: 10.1016/s0360-3016(97)00127-2.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDisease-free survivalT2 patientsCrude relapse rateAdjuvant therapyOverall survivalElectron beam therapyRelapse rateEntire cohortMedian disease-free survivalCutaneous T-cell lymphomaBeam therapySalvage of recurrencesAdjuvant systemic therapyEarly-stage patientsManagement of patientsT-cell lymphomaTopical nitrogen mustardDays/weekCombination of therapiesGy/dayTreatments/weekPUVA patientsMedian followSalvage therapy
1987
Combined total body electron beam irradiation and chemotherapy for mycosis fungoides
Braverman I, Yager N, Chen M, Cadman E, Hait W, Maynard T. Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. Journal Of The American Academy Of Dermatology 1987, 16: 45-60. PMID: 3100583, DOI: 10.1016/s0190-9622(87)70004-8.Peer-Reviewed Original ResearchConceptsComplete clinical remissionElectron beam therapyMycosis fungoidesClinical remissionBeam therapyKaplan-Meier methodElevated blood levelsSignificant differencesGeneralized Wilcoxon testSézary cellsCombination therapyBlood levelsControl subjectsActuarial analysisStage IStage IIIPatientsFungoidesTherapyKaryotypic abnormalitiesMonthly cyclesWilcoxon testRemissionChemotherapyStatistical analysis